422 related articles for article (PubMed ID: 10339589)
1. Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein.
Yamadori T; Baba Y; Matsushita M; Hashimoto S; Kurosaki M; Kurosaki T; Kishimoto T; Tsukada S
Proc Natl Acad Sci U S A; 1999 May; 96(11):6341-6. PubMed ID: 10339589
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK).
Matsushita M; Yamadori T; Kato S; Takemoto Y; Inazawa J; Baba Y; Hashimoto S; Sekine S; Arai S; Kunikata T; Kurimoto M; Kishimoto T; Tsukada S
Biochem Biophys Res Commun; 1998 Apr; 245(2):337-43. PubMed ID: 9571151
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.
Wahl MI; Fluckiger AC; Kato RM; Park H; Witte ON; Rawlings DJ
Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11526-33. PubMed ID: 9326643
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
Qin S; Chock PB
Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
[TBL] [Abstract][Full Text] [Related]
5. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
6. An SH3-binding site conserved in Bruton's tyrosine kinase and related tyrosine kinases mediates specific protein interactions in vitro and in vivo.
Yang W; Malek SN; Desiderio S
J Biol Chem; 1995 Sep; 270(35):20832-40. PubMed ID: 7657668
[TBL] [Abstract][Full Text] [Related]
7. The SH3 domain of Bruton's tyrosine kinase interacts with Vav, Sam68 and EWS.
Guinamard R; Fougereau M; Seckinger P
Scand J Immunol; 1997 Jun; 45(6):587-95. PubMed ID: 9201297
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Bruton's tyrosine kinase by c-Abl.
Bäckesjö CM; Vargas L; Superti-Furga G; Smith CI
Biochem Biophys Res Commun; 2002 Dec; 299(3):510-5. PubMed ID: 12445832
[TBL] [Abstract][Full Text] [Related]
9. The protein product of the c-cbl protooncogene is phosphorylated after B cell receptor stimulation and binds the SH3 domain of Bruton's tyrosine kinase.
Cory GO; Lovering RC; Hinshelwood S; MacCarthy-Morrogh L; Levinsky RJ; Kinnon C
J Exp Med; 1995 Aug; 182(2):611-5. PubMed ID: 7629518
[TBL] [Abstract][Full Text] [Related]
10. Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).
Gustafsson MO; Hussain A; Mohammad DK; Mohamed AJ; Nguyen V; Metalnikov P; Colwill K; Pawson T; Smith CI; Nore BF
Mol Cell Biol; 2012 Jul; 32(13):2440-53. PubMed ID: 22527282
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.
Vassilev A; Ozer Z; Navara C; Mahajan S; Uckun FM
J Biol Chem; 1999 Jan; 274(3):1646-56. PubMed ID: 9880544
[TBL] [Abstract][Full Text] [Related]
12. Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.
Liu W; Quinto I; Chen X; Palmieri C; Rabin RL; Schwartz OM; Nelson DL; Scala G
Nat Immunol; 2001 Oct; 2(10):939-46. PubMed ID: 11577348
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of CD19 Y484 and Y515, and linked activation of phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase.
Buhl AM; Cambier JC
J Immunol; 1999 Apr; 162(8):4438-46. PubMed ID: 10201980
[TBL] [Abstract][Full Text] [Related]
14. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.
Hashimoto S; Iwamatsu A; Ishiai M; Okawa K; Yamadori T; Matsushita M; Baba Y; Kishimoto T; Kurosaki T; Tsukada S
Blood; 1999 Oct; 94(7):2357-64. PubMed ID: 10498607
[TBL] [Abstract][Full Text] [Related]
15. BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma B cells.
Uckun FM; Waddick KG; Mahajan S; Jun X; Takata M; Bolen J; Kurosaki T
Science; 1996 Aug; 273(5278):1096-100. PubMed ID: 8688094
[TBL] [Abstract][Full Text] [Related]
16. In situ detection of activated Bruton's tyrosine kinase in the Ig signaling complex by phosphopeptide-specific monoclonal antibodies.
Nisitani S; Kato RM; Rawlings DJ; Witte ON; Wahl MI
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2221-6. PubMed ID: 10051622
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Btk function by a major autophosphorylation site within the SH3 domain.
Park H; Wahl MI; Afar DE; Turck CW; Rawlings DJ; Tam C; Scharenberg AM; Kinet JP; Witte ON
Immunity; 1996 May; 4(5):515-25. PubMed ID: 8630736
[TBL] [Abstract][Full Text] [Related]
18. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl.
Patel HV; Tzeng SR; Liao CY; Chen SH; Cheng JW
Proteins; 1997 Dec; 29(4):545-52. PubMed ID: 9408950
[TBL] [Abstract][Full Text] [Related]
19. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement.
Yang W; Desiderio S
Proc Natl Acad Sci U S A; 1997 Jan; 94(2):604-9. PubMed ID: 9012831
[TBL] [Abstract][Full Text] [Related]
20. A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells.
Tomlinson MG; Woods DB; McMahon M; Wahl MI; Witte ON; Kurosaki T; Bolen JB; Johnston JA
BMC Immunol; 2001; 2():4. PubMed ID: 11410123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
